Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Esperion Therapeutics Inc | ESPR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 1.46 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.46 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 1.26 - 8.87 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 1.46 | USD |
Esperion Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 111.80M | 76.57M | 63.85M | $ 75.48M | $ -50.46M | -3.53 | -1.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 102.46k | 2.30% |
Esperion Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ESPR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.49 | 2.16 | 1.26 | 1.71 | 17,901,038 | -0.03 | -2.01% |
| 1 Month | 5.69 | 6.745 | 1.26 | 3.28 | 7,595,406 | -4.23 | -74.34% |
| 3 Months | 5.93 | 7.41 | 1.26 | 4.06 | 3,720,156 | -4.47 | -75.38% |
| 6 Months | 6.84 | 8.87 | 1.26 | 5.03 | 2,690,798 | -5.38 | -78.65% |
| 1 Year | 5.50 | 8.87 | 1.26 | 5.38 | 1,898,018 | -4.04 | -73.45% |
| 3 Years | 34.30 | 53.73 | 1.26 | 12.26 | 1,255,166 | -32.84 | -95.74% |
| 5 Years | 70.18 | 79.989 | 1.26 | 21.26 | 1,027,210 | -68.72 | -97.92% |
Esperion Therapeutics Description
| Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. |